0.0135
-0.0058
(-30.05%)
As of 8:00:27 AM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Christian Lindholm | CFO & Executive VP | 2.28M | -- | 1964 |
Acarix AB (publ)
Regus MalmOe
Hyllie Boulevard 34, 5TR
Malmö, 215 32
Sweden
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Corporate Governance
Acarix AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 12, 2025 at 10:59 AM UTC
Acarix AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available